Interventional Cardiology & Surgery

heartwire News

  • ESC Data Bolster Dual Antithrombotic Therapy in AF PCI Patients A new study supports forgoing traditional triple antithrombotic therapy with aspirin for dual therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation who've undergone PCI.
  • ESC ESC Guideline Update on Dual Antiplatelet Therapy in CAD The latest advice in this controversial area advocates a personalized-medicine approach based on ischemic vs bleeding risks, where each treatment and its duration is individualized as much as possible.
  • ESC Fentanyl in the Cath Lab: Routine but Risky? New data show the potent intravenous opiate weakens the antiplatelet effects of ticagrelor during PCI, challenging its routine and prophylactic use for cardiac catheterization and PCI in the US.
  • ESC New ESC Guideline on Peripheral Arterial Disease Patients with peripheral arterial disease often have comorbid cardiovascular and noncardiovascular conditions and should therefore be offered multidisciplinary care, recommend new European guidelines.

Perspective